125 related articles for article (PubMed ID: 8143369)
1. Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy.
Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
Clin Chim Acta; 1993 Dec; 223(1-2):43-52. PubMed ID: 8143369
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen, serum lipoproteins and cardiovascular risk.
Bruning PF; Bonfrer JM; Hart AA; de Jong-Bakker M; Linders D; van Loon J; Nooyen WJ
Br J Cancer; 1988 Oct; 58(4):497-9. PubMed ID: 3207604
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
Ilanchezhian S; Thangaraju M; Sachdanandam P
Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
[TBL] [Abstract][Full Text] [Related]
4. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
Love RR; Newcomb PA; Wiebe DA; Surawicz TS; Jordan VC; Carbone PP; DeMets DL
J Natl Cancer Inst; 1990 Aug; 82(16):1327-32. PubMed ID: 2199681
[TBL] [Abstract][Full Text] [Related]
6. Effect of tamoxifen on fibrinogen, D-dimer, lipid and lipoprotein concentrations in breast cancer patients.
Genç S; Tanrikulu-Kiliç F; Gürdöl F; Unlüçerçi Y; Uler P; Lama A; Unur N
Clin Chim Acta; 2003 Nov; 337(1-2):177-9. PubMed ID: 14568197
[No Abstract] [Full Text] [Related]
7. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
[TBL] [Abstract][Full Text] [Related]
8. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
[TBL] [Abstract][Full Text] [Related]
9. Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer.
Joensuu H; Holli K; Oksanen H; Valavaara R
Breast Cancer Res Treat; 2000 Oct; 63(3):225-34. PubMed ID: 11110056
[TBL] [Abstract][Full Text] [Related]
10. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
[TBL] [Abstract][Full Text] [Related]
11. A study of the effect of tamoxifen on serum lipoprotein profiles in premenopausal and postmenopausal women with breast carcinoma and associated risk of cardiovascular disease.
Sharma D; Sharma U; Bhatnagar VB; Singh VS
Indian J Med Sci; 2001 Jul; 55(7):359-65. PubMed ID: 11883334
[TBL] [Abstract][Full Text] [Related]
12. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
Wasan KM; Ramaswamy M; Haley J; Dunn BP
J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytotoxic chemotherapy on serum lipid levels in breast cancer patients.
Rzymowska J
Pathobiology; 1999; 67(3):129-32. PubMed ID: 10394133
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.
Love RR; Wiebe DA; Newcomb PA; Cameron L; Leventhal H; Jordan VC; Feyzi J; DeMets DL
Ann Intern Med; 1991 Dec; 115(11):860-4. PubMed ID: 1952472
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Esteva FJ; Hortobagyi GN
Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
[TBL] [Abstract][Full Text] [Related]
16. The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property.
Elisaf M; Bairaktari E; Nicolaides C; Fountzilas G; Tzallas C; Siamopoulos K; Tsolas O; Pavlidis N
Anticancer Res; 1996; 16(5A):2725-8. PubMed ID: 8917378
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen.
Rössner S; Wallgren A
Atherosclerosis; 1984 Sep; 52(3):339-46. PubMed ID: 6497936
[TBL] [Abstract][Full Text] [Related]
18. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.
Vehmanen L; Saarto T; Blomqvist C; Taskinen MR; Elomaa I
Br J Cancer; 2004 Aug; 91(3):476-81. PubMed ID: 15266329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
